Skip to main content
Iona Munjal, MD, Pediatric Infectious Disease, Bronx, NY

IonaMunjalMD

Pediatric Infectious Disease Bronx, NY

Assistant Professor of Pediatrics

Dr. Munjal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Munjal's full profile

Already have an account?

  • Office

    Albert Einstein College of Medicine
    Pediatrics
    Bronx, NY 10467
    Phone+1 718-741-2471

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Infectious Diseases, 2009 - 2012
  • Icahn School of Medicine at Mount Sinai/Kravis Children's
    Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 2005 - 2009
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2007 - 2026
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases

Publications & Presentations

PubMed

Journal Articles

  • Predictors of Inadequate Initial Echocardiography in Suspected Kawasaki Disease: Criteria for Sedation  
    Nadine F Choueiter, Iona M Munjal, Chhavi Katyal, Congenital Heart Disease

Press Mentions

  • International and Regional Experts Address the Role of Vaccines in Disease Management During Pfizer MERA Vaccines Summit 2024
    International and Regional Experts Address the Role of Vaccines in Disease Management During Pfizer MERA Vaccines Summit 2024November 4th, 2024
  • Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect Infants
    Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect InfantsMarch 23rd, 2023
  • Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59
    Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59April 10th, 2024
  • Join now to see all